DOUGLAS ORR, MD
Medical Oncology Physician · DALLAS, TX
Individual Active NPI 1194767061
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 222 | 42,044 | $2,563,137 | $754,383 | $597,472 |
| 2023 | 427 | 88,827 | $6,484,172 | $1,873,513 | $1,489,674 |
| 2022 | 494 | 106,788 | $7,519,402 | $2,180,340 | $1,739,140 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| J1453 | Injection, fosaprepitant, 1 mg | 5,400 | $0 | $0 |
| J9271 | Injection, pembrolizumab, 1 mg | 3,600 | $56 | $44 |
| J9267 | Injection, paclitaxel, 1 mg | 2,088 | $0 | $0 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 1,650 | $0 | $0 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 622 | $0 | $0 |
| J2469 | Injection, palonosetron hcl, 25 mcg | 420 | $1 | $1 |
| 96367 | Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 136 | $28 | $21 |
| J1626 | Injection, granisetron hydrochloride, 100 mcg | 120 | $0 | $0 |
| J9190 | Injection, fluorouracil, 500 mg | 99 | $3 | $2 |
| J3475 | Injection, magnesium sulfate, per 500 mg | 96 | $1 | $1 |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | 80 | $126 | $96 |
| 96375 | Injection of additional new drug or substance into vein | 80 | $15 | $12 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Medical Oncology Physician | 207RX0202X | ✓ | H7202 | TX |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- Yes
Other Medical Oncology Physician providers in Texas
- NPI 1962595090
- NPI 1407898505
- NPI 1821257072
- NPI 1225328743
- NPI 1528591047
- NPI 1326368895
- NPI 1154530830
- NPI 1235171281
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.